盟科药业 (688373.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(盟科药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年中报2022年一季报2021年年报2021年中报2021年一季报2020年年报
上市前/上市后 上市前上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 20,382,644.0210,686,996.607,660,011.80---
 营业收入(元) 20,382,644.0210,686,996.607,660,011.80---
二、营业总成本(元) 133,324,416.2066,088,248.48279,963,457.01107,894,506.7445,391,328.3196,925,742.27
 营业成本(元) 3,569,469.711,587,704.12578,377.42---
 研发费用(元) 65,547,213.9332,916,057.99151,757,742.5957,175,818.8525,298,342.3954,282,004.50
 营业税金及附加(元) 95,573.674,991.7033,505.7259.131.45355,337.49
 销售费用(元) 31,283,850.0515,214,284.6766,217,478.8422,793,535.419,701,088.114,373,994.25
 管理费用(元) 28,475,665.2614,541,332.2158,161,329.9327,196,307.2310,829,915.0836,454,520.91
 财务费用(元) 4,352,643.581,703,400.333,215,022.51728,786.12-296,323.231,459,885.12
  其中:利息费用(元) -2,230,897.775,231,671.01-91,741.822,435,887.44
  其中:利息收入(元) --636,542.37-2,394,413.38--366,697.38-999,579.82
三、其他经营收益
 加:公允价值变动收益(元) 2,991,922.322,103,819.7510,529,537.305,529,357.853,243,592.58-140,518.49
 资产处置收益(元) 520,241.57520,241.57----3,936.41
 资产减值损失(元) ---181,193.94-181,193.94--
 信用减值损失(元) -157,556.60--339,985.54-6,429.81--10,899.48
 其他收益(元) 108,280.8939,338.956,146,168.85124,051.3027,922.00251,889.12
 营业利润平衡项目(元) -0.01-----
四、营业利润(元) -109,478,884.01-52,737,851.61-256,148,918.54-102,428,721.34-42,119,813.73-96,829,207.53
 加:营业外收入(元) 1,749,337.111,713,415.9929,939,176.0715,629,778.206,718,702.7110,517,415.77
 减:营业外支出(元) 13,037.1013,037.1121,599.771,683.021,683.029,924.55
五、利润总额(元) -107,742,584.00-51,037,472.73-226,231,342.24-86,800,626.16-35,402,794.04-86,321,716.31
 减:所得税费用(元) 5,186.82-38,857.935,131.765,187.555,518.10
六、净利润(元) -107,747,770.82-51,037,472.73-226,270,200.17-86,805,757.92-35,407,981.59-86,327,234.41
(一)按经营持续性分类
  持续经营净利润(元) --51,037,472.73---35,407,981.59-
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -107,747,770.82-51,037,472.73-226,270,200.17-86,805,757.92-35,407,981.59-86,327,234.41
 扣除非经常性损益后的净利润(元) -112,999,700.00-55,401,300.00-264,277,500.00-108,087,300.00-45,396,500.00-67,015,300.00
七、每股收益
 一、基本每股收益(元) -0.21-0.10-0.43-0.17-0.07-0.34
 二、稀释每股收益(元) --0.10-0.43--0.07-0.34
八、其他综合收益(元) 2,415,230.72-104,947.83-973,270.59135,627.81-42,802.181,792,625.54
 归属于母公司股东的其他综合收益(元) 2,415,230.72-104,947.83-973,270.59135,627.81-42,802.181,792,625.54
九、综合收益总额(元) -105,332,540.09-51,142,420.56-227,243,470.76-86,670,130.11-35,450,783.77-84,534,608.87
 归属于母公司所有者的综合收益总额(元) -105,332,540.09-51,142,420.56-227,243,470.76-86,670,130.11-35,450,783.77-84,534,608.87
公告日期 2022-08-042022-07-192022-04-062021-11-052022-07-192021-11-05
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院